These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 33160341
1. Willingness to use HIV prevention methods among vaccine efficacy trial participants in Soweto, South Africa: discretion is important. Laher F, Salami T, Hornschuh S, Makhale LM, Khunwane M, Andrasik MP, Gray GE, Van Tieu H, Dietrich JJ. BMC Public Health; 2020 Nov 07; 20(1):1669. PubMed ID: 33160341 [Abstract] [Full Text] [Related]
2. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa. Cheng CY, Quaife M, Eakle R, Cabrera Escobar MA, Vickerman P, Terris-Prestholt F. BMC Public Health; 2019 Jul 24; 19(1):996. PubMed ID: 31340785 [Abstract] [Full Text] [Related]
3. A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa. Dietrich JJ, Hornschuh S, Khunwane M, Makhale LM, Otwombe K, Morgan C, Huang Y, Lemos M, Lazarus E, Kublin JG, Gray GE, Laher F, Andrasik M, HVTN 915 team. PLoS One; 2020 Jul 24; 15(4):e0231086. PubMed ID: 32324753 [Abstract] [Full Text] [Related]
4. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study. Mack N, Evens EM, Tolley EE, Brelsford K, Mackenzie C, Milford C, Smit JA, Kimani J. J Int AIDS Soc; 2014 Jul 24; 17(3 Suppl 2):19157. PubMed ID: 25224616 [Abstract] [Full Text] [Related]
8. Perspectives of South African youth in the development of an implant for HIV prevention. Krogstad EA, Atujuna M, Montgomery ET, Minnis A, Ndwayana S, Malapane T, Shapley-Quinn MK, Manenzhe K, Bekker LG, van der Straten A. J Int AIDS Soc; 2018 Aug 24; 21(8):e25170. PubMed ID: 30152004 [Abstract] [Full Text] [Related]
12. Preferences for ARV-based HIV prevention methods among men and women, adolescent girls and female sex workers in Gauteng Province, South Africa: a protocol for a discrete choice experiment. Quaife M, Eakle R, Cabrera M, Vickerman P, Tsepe M, Cianci F, Delany-Moretlwe S, Terris-Prestholt F. BMJ Open; 2016 Jun 27; 6(6):e010682. PubMed ID: 27354071 [Abstract] [Full Text] [Related]
14. "It's already in your body and it's preventing": a qualitative study of African female adolescent's acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa. Fynn L, Gill K, Wallace M, Atujuna M, Duyver M, Ngcobo P, Spiegel H, Rinehart A, Hosek S, Bekker LG. BMC Public Health; 2023 Nov 02; 23(1):2143. PubMed ID: 37919697 [Abstract] [Full Text] [Related]
17. Participants' characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa. Hanass-Hancock J, Carpenter B, Reddy T, Nzuza A, Gaffoor Z, Goga A, Andrasik M. Trials; 2021 Dec 11; 22(1):897. PubMed ID: 34895272 [Abstract] [Full Text] [Related]
18. Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities. Mansergh G, Kota KK, Stephenson R, Hirshfield S, Sullivan P. J Int AIDS Soc; 2021 Jan 11; 24(1):e25664. PubMed ID: 33481359 [Abstract] [Full Text] [Related]
19. Understanding women and men's acceptability of current and new HIV prevention technologies in KwaZulu-Natal, South Africa. Govender E, Abdool Karim Q. AIDS Care; 2018 Oct 11; 30(10):1311-1314. PubMed ID: 29914270 [Abstract] [Full Text] [Related]
20. Gender and Power Dynamics of Social Relationships Shape Willingness to Participate in Biomedical HIV Prevention Research Among South African Adolescents and Young Adults. Closson K, Lee L, Dietrich JJ, Beksinska ME, Hornschuh S, Smith P, Smit JA, Ndung'u T, Brockman M, Gray G, Kaida A. Front Reprod Health; 2021 Oct 11; 3():639391. PubMed ID: 36304054 [Abstract] [Full Text] [Related] Page: [Next] [New Search]